Low-dose Nalmefene
Cross-source consensus on Low-dose Nalmefene from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Benefits
Dosage & preparation
Highlighted claims
- A single intravenous nalmefene dose of 0.25 micrograms/kg was administered at completion of skin suturing in the intervention group. — Efficacy of low-dose nalmefene on recovery from general anaesthesia in adult patients: a multicentre randomised controlled study
- Low-dose nalmefene significantly shortened the time to PACU recovery readiness compared with saline. — Efficacy of low-dose nalmefene on recovery from general anaesthesia in adult patients: a multicentre randomised controlled study
- Nalmefene is described as a long-acting antagonist of mu, kappa, and delta opioid receptors. — Efficacy of low-dose nalmefene on recovery from general anaesthesia in adult patients: a multicentre randomised controlled study
- The precise mechanisms by which low-dose nalmefene preserved or improved analgesia remain unresolved. — Efficacy of low-dose nalmefene on recovery from general anaesthesia in adult patients: a multicentre randomised controlled study
- The trial frames the approximately 9-10 minute reduction in PACU recovery endpoint time as clinically meaningful. — Efficacy of low-dose nalmefene on recovery from general anaesthesia in adult patients: a multicentre randomised controlled study